Alimera’s ILUVIEN® receives positive NICE recommendation for NIPU
Alimera Sciences announces the UK's NICE, in its Final Appraisal Determination for national reimbursement, has recommended funding for ILUVIEN 190 micrograms intravitreal implant in applicator for prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment. June 20, 2019